On April 26, 2026, Indonesia’s National Agency of Drug and Food Control (BPOM) issued Circular No. SE.03.02.2/2221/2026, mandating new labeling requirements for imported natural ingredients — specifically requiring explicit declaration of microbial tolerance to pH ≤4.6 and heat treatment at 60°C for 30 minutes. The rule takes effect on August 1, 2026, and directly affects Chinese exporters of enzyme powders, plant-based fermented extracts, and other natural ingredient categories cleared through Indonesian customs.

Event Overview

On April 26, 2026, BPOM published Circular No. SE.03.02.2/2221/2026, stipulating that all imported natural ingredients must declare on their labels: ‘Validated to withstand pH ≤4.6 and thermal treatment at 60°C for 30 minutes.’ Without this statement, shipments will not be permitted to clear Indonesian customs. The regulation applies to natural ingredients originating from China, including but not limited to enzyme powders and plant fermentation extracts. The effective date is August 1, 2026.

Which Subsectors Are Affected

Direct Exporters & Trading Companies

These entities are directly responsible for label compliance prior to shipment. Non-compliant labels will result in customs rejection, leading to delays, rework costs, or cargo return. Since labeling must reflect validated technical specifications — not generic claims — exporters must verify and document tolerance data with supporting test reports before printing labels.

Raw Material Sourcing & Procurement Firms

Firms procuring natural ingredients for export face upstream alignment challenges. If suppliers (e.g., domestic Chinese manufacturers) do not provide validated microbial tolerance data or cannot adjust processing parameters to meet the requirement, procurement teams may need to reassess vendor qualifications or reformulate sourcing strategies ahead of the August 2026 deadline.

Manufacturers & Formulators

Manufacturers producing enzyme powders or fermented extracts must ensure their current production processes — especially post-fermentation stabilization, drying, and packaging steps — consistently yield products meeting the specified pH and thermal stability thresholds. Process validation and documentation become critical prerequisites, not optional quality add-ons.

Logistics & Customs Compliance Service Providers

Third-party service providers handling Indonesian import documentation must now verify label content against BPOM’s exact phrasing. Automated label review systems may require updates to flag missing or non-standard wording. Pre-clearance verification workflows will need adjustment to include tolerance statement checks as a mandatory checkpoint.

What Relevant Enterprises or Practitioners Should Focus On Now

Confirm official terminology and scope interpretation with BPOM guidance

While the circular specifies the required statement, BPOM has not yet published accompanying technical guidelines (e.g., acceptable test methods, minimum sample sizes, or certification formats). Enterprises should monitor BPOM’s official portal and consult licensed Indonesian regulatory agents for authoritative interpretations before finalizing label drafts.

Identify high-risk SKUs and prioritize validation for top-exported items

Not all natural ingredient SKUs face equal risk. Enzyme powders and fermented botanical extracts — explicitly named in the notice — should be prioritized for internal review and third-party testing. Companies exporting multiple variants (e.g., different pH-adjusted batches or thermal profiles) must map each SKU to its corresponding tolerance evidence.

Distinguish between regulatory signal and operational implementation

The issuance of the circular signals BPOM’s intent to strengthen microbiological safety oversight for natural ingredients. However, enforcement rigor — such as whether inspectors will request lab reports during clearance or accept manufacturer declarations — remains unconfirmed. Current preparations should assume full documentation requirements unless clarified otherwise by BPOM.

Initiate cross-functional alignment on labeling, testing, and supply chain timelines

Updating labels requires coordination across R&D, QA/QC, regulatory affairs, procurement, and logistics. Companies should convene internal task forces to assess lead times for test validation, label reprinting, inventory turnover, and supplier communication — especially given the ~3.5-month window between publication and enforcement.

Editorial Perspective / Industry Observation

From an industry perspective, this update is better understood as a procedural tightening within BPOM’s existing food safety framework — not a de novo safety standard. It reflects increased scrutiny of natural ingredients’ functional stability under common food processing conditions, particularly acidic and mild-heat environments typical in beverage and supplement manufacturing. Analysis来看, the requirement appears calibrated to prevent microbial proliferation risks during downstream use, rather than targeting raw material contamination alone. Observation来看, BPOM’s focus on verifiable, process-linked claims — rather than broad ‘natural’ or ‘safe’ assertions — suggests a broader regulatory shift toward evidence-based labeling in Indonesia’s health product segment. Current more relevant interpretation is that this serves as both a compliance milestone and an early indicator of tighter technical expectations for functional ingredient imports across ASEAN markets.

This regulation underscores how national-level labeling updates — even without changes to safety limits or approval pathways — can significantly reshape operational priorities for exporters. Its significance lies less in novelty and more in enforceability: it introduces a binary, documentary gate at customs, making advance preparation essential. For stakeholders, it is best interpreted not as a one-off compliance hurdle, but as a marker of evolving regulatory maturity in Indonesia’s natural ingredients market — where technical transparency increasingly substitutes for categorical exemptions.

Source: Indonesia National Agency of Drug and Food Control (BPOM), Circular No. SE.03.02.2/2221/2026, issued April 26, 2026. Note: Technical implementation details (e.g., accepted test protocols, certification format, or inspector verification procedures) remain pending official clarification and are subject to ongoing observation.